Front & Back Matter.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 1, doi. 10.1159/000533997
- Publication type:
- Article
Works matching IS 16608151 AND DT 2023 AND VI 147 AND IP 8
Results: 8
1
2
The CARDINAL Trial of Bardoxolone Methyl in Alport Syndrome: When Marketing Interests Prevail over Patients Clinical Needs.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 465, doi. 10.1159/000529471
- By:
- Publication type:
- Article
3
Piceatannol Protects against High Glucose-Induced Injury of Renal Tubular Epithelial Cells via Regulating Carbonic Anhydrase 2.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 496, doi. 10.1159/000529212
- By:
- Publication type:
- Article
4
Leptospirosis: A Potential Culprit for Chronic Kidney Disease of Uncertain Etiology.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 510, doi. 10.1159/000528703
- By:
- Publication type:
- Article
5
Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 478, doi. 10.1159/000528557
- By:
- Publication type:
- Article
6
Kidney Disease and Viral Infection in COVID-19: Why Are Kidney Organoid and Biopsy Studies Not in Agreement?
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 458, doi. 10.1159/000528460
- By:
- Publication type:
- Article
7
A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 470, doi. 10.1159/000528344
- By:
- Publication type:
- Article
8
Neuronal Proteins as Antigenic Targets in Membranous Nephropathy.
- Published in:
- Nephron, 2023, v. 147, n. 8, p. 451, doi. 10.1159/000528078
- By:
- Publication type:
- Article